DRKS00024412Completed未知
Quantification of the reduction on the viral load (SARS-CoV-2) on persons with COVID-19 after gargling with Linola sept mouthwash
niversitätsklinik für Hals-, Nasen- und Ohrenheilkunde, Kopf- und Halschirurgie Campus Klinikum Bielefeld, Medizinische Fakultät OWL, Universität Bielefeld0 sites50 target enrollmentStarted: February 15, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized controlled study
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to 100 Years (—)
- Sex
- All
Inclusion Criteria
- •Willingness to participate
- •-Signed written consent
- •-Positive SARS-CoV-2 test using a pharyngeal swab
- •-CT-value < 37
Exclusion Criteria
- •Allergies on at least one of the ingredients.
Investigators
Similar Trials
Withdrawn
Phase 2
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza InfectionInfluenzaNCT01992276Crucell Holland BV
Completed
Not Applicable
Europe - Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Genital Secretions Substudy IIISRCTN57333945Medical Research Council [MRC] Clinical Trials Unit (UK)200
Completed
Not Applicable
Anti-viral photodynamic therapy in COVID-19 management: a novel approach in treating patients in early infection stagesISRCTN10839729International Society for Medical Laser Applications140
Not yet recruiting
Not Applicable
Clinical severity and outcome among covid-19 infected patients in respect to viral load and immune & inflammatory response.CTRI/2020/07/026755RUHS College of Medical Sciences
Withdrawn
Phase 2
the Study to Evaluate the Safety of UB-421 in Combination With Antiretroviral Therapy (ART) and the Efficacy in Reduction of HIV Viral Load and Proviral DNA as Compared to ART Alone in ART-experienced Viremic HIV-1 PatientsHIV-1 InfectionNCT04041362United BioPharma